Viewing Study NCT00812968


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT00812968
Status: COMPLETED
Last Update Posted: 2019-11-19
First Post: 2008-12-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.
Sponsor: Celgene
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CC-5013-MDS-007
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators